The Laquinimod ALLEGRO study started in 2007 and was double-blinded. What non-placebo comparator could possibly have been used that would have allowed blinding?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.